Date: 04.11.2026

Board Meeting Outcomes

The Board of Directors meeting held on November 04, 2026, from 4:45 PM to 6:00 PM, approved the following:

  • Unaudited standalone and consolidated financial results for the quarter ended September 30, 2026
  • Limited Review Report of the Statutory Auditors, M/s. Y M Shah & Co., Vadodara, on the unaudited financial results (standalone and consolidated)

The company declared that the auditor's reports on both standalone and consolidated financial results are unmodified.

Financial Results (Standalone)

Income Statement (Quarter Ended September 30, 2026)

  • Revenue From Operations: ₹80.36 Cr (vs ₹96.43 Cr in Q2 FY2026)
  • Other Income: ₹5.21 Cr (vs ₹1.51 Cr in Q2 FY2026)
  • Total Income: ₹85.57 Cr (vs ₹96.58 Cr in Q2 FY2026)
  • Total Expenses: ₹643.78 Cr
  • Profit Before Tax: ₹211.88 Cr (vs ₹312.44 Cr in Q2 FY2026)
  • Total Tax Expense: ₹34.28 Cr
  • Profit After Tax: ₹177.64 Cr (vs ₹230.12 Cr in Q2 FY2026)
  • Other Comprehensive Income: ₹(7.16) Cr
  • Total Comprehensive Income: ₹170.48 Cr
  • Basic EPS: ₹0.23 (vs ₹0.45 in Q2 FY2026)
  • Diluted EPS: ₹0.23 (vs ₹0.45 in Q2 FY2026)

Income Statement (Half Year Ended September 30, 2026)

  • Revenue From Operations: ₹172.78 Cr
  • Other Income: ₹11.66 Cr
  • Total Income: ₹184.45 Cr
  • Profit Before Tax: ₹477.10 Cr
  • Total Tax Expense: ₹95.75 Cr
  • Profit After Tax: ₹381.35 Cr
  • Other Comprehensive Income: ₹(7.45) Cr
  • Total Comprehensive Income: ₹373.90 Cr
  • Basic EPS: ₹0.48
  • Diluted EPS: ₹0.48

Balance Sheet (Standalone as at September 30, 2026)

  • Total Assets: ₹269.39 Cr
  • Non-current Assets: ₹220.18 Cr
  • Property, Plant and Equipment: ₹149.44 Cr
  • Right of Use Assets: ₹25.55 Cr
  • Goodwill: ₹71.31 Cr
  • Investments: ₹128.52 Cr
  • Other non-current assets: ₹65.88 Cr
  • Current Assets: ₹49.21 Cr
  • Inventories: ₹0.97 Cr
  • Trade receivables: ₹19.66 Cr
  • Cash and cash equivalents: ₹2.86 Cr
  • Bank balances: ₹19.06 Cr
  • Loans: ₹2.65 Cr
  • Total Equity: ₹250.17 Cr
  • Share Capital: ₹15.77 Cr
  • Other Equity: ₹234.40 Cr
  • Non-current liabilities: ₹2.98 Cr
  • Current liabilities: ₹19.22 Cr

Cash Flow Statement (Standalone Half Year Ended September 30, 2026)

  • Net cash used in operating activities: ₹(51.62) Cr
  • Net cash generated by investing activities: ₹37.17 Cr
  • Net cash used in financing activities: ₹(11.15) Cr
  • Net decrease in cash and cash equivalents: ₹(25.61) Cr

Financial Results (Consolidated)

Income Statement (Quarter Ended September 30, 2026)

  • Revenue From Operations: ₹380.90 Cr (vs ₹129.29 Cr in Q2 FY2026)
  • Other Income: ₹58.67 Cr (vs ₹8.79 Cr in Q2 FY2026)
  • Total Income: ₹386.77 Cr (vs ₹130.07 Cr in Q2 FY2026)
  • Total Expenses: ₹3,005.20 Cr
  • Profit Before Tax: ₹862.49 Cr (vs ₹403.06 Cr in Q2 FY2026)
  • Total Tax Expense: ₹202.69 Cr
  • Profit After Tax: ₹659.80 Cr (vs ₹287.64 Cr in Q2 FY2026)
  • Other Comprehensive Income: ₹(0.82) Cr
  • Total Comprehensive Income: ₹650.98 Cr
  • Profit attributable to owners: ₹584.21 Cr
  • Profit attributable to non-controlling interests: ₹75.58 Cr
  • Basic EPS: ₹0.74 (vs ₹0.52 in Q2 FY2026)
  • Diluted EPS: ₹0.74 (vs ₹0.52 in Q2 FY2026)

Income Statement (Half Year Ended September 30, 2026)

  • Revenue From Operations: ₹723.79 Cr
  • Other Income: ₹127.57 Cr
  • Total Income: ₹736.55 Cr
  • Profit Before Tax: ₹1,558.84 Cr
  • Total Tax Expense: ₹366.94 Cr
  • Profit After Tax: ₹1,191.90 Cr
  • Other Comprehensive Income: ₹1.19 Cr
  • Total Comprehensive Income: ₹1,203.09 Cr
  • Profit attributable to owners: ₹1,102.36 Cr
  • Profit attributable to non-controlling interests: ₹89.54 Cr
  • Basic EPS: ₹1.40
  • Diluted EPS: ₹1.40

Balance Sheet (Consolidated as at September 30, 2026)

  • Total Assets: ₹326.72 Cr
  • Non-current Assets: ₹242.20 Cr
  • Property, Plant and Equipment: ₹319.26 Cr
  • Right of Use Assets: ₹100.98 Cr
  • Goodwill: ₹107.42 Cr
  • Investments: ₹12.00 Cr
  • Other non-current assets: ₹53.91 Cr
  • Current Assets: ₹103.29 Cr
  • Inventories: ₹2.05 Cr
  • Trade receivables: ₹420.35 Cr
  • Cash and cash equivalents: ₹121.10 Cr
  • Bank balances: ₹200.67 Cr
  • Loans: ₹2.65 Cr
  • Total Equity: ₹263.64 Cr
  • Share Capital: ₹15.77 Cr
  • Other Equity: ₹247.87 Cr
  • Non-controlling interests: ₹62.26 Cr
  • Non-current liabilities: ₹156.81 Cr
  • Current liabilities: ₹412.66 Cr

Cash Flow Statement (Consolidated Half Year Ended September 30, 2026)

  • Net cash generated by operating activities: ₹4.17 Cr
  • Net cash used in investing activities: ₹(200.58) Cr
  • Net cash used in financing activities: ₹(19.83) Cr
  • Net decrease in cash and cash equivalents: ₹(178.73) Cr

Subsidiaries and Entities Included in Consolidation

The consolidated results include the following entities:

  • Gujarat Surgical Hospital (Entity under Control)
  • Surya Hospital and ICU (Entity under Control)
  • Palmland Hospital Private Limited (Subsidiary)
  • Harmony Medicare Private Ltd (Subsidiary)
  • Parekh Hospital Private Ltd (Subsidiary)
  • Patel Multispeciality Hospital And ICU (Entity under Control)
  • Patel Pharmacy (Entity under Control)
  • Blue Tree Clinic LLC (Subsidiary)

Notes to Financial Results

The financial results have been prepared in accordance with Indian Accounting Standard (Ind AS) 34 - Interim Financial Reporting and comply with SEBI Listing Regulations. The company operates in a single primary business segment, making segment reporting under Ind-AS 108 not applicable. EPS has been computed in accordance with Ind-AS 33. Previous period figures have been regrouped/rearranged where necessary.